A recent survey conducted by Strupp et al. (2025), analyzed intervention trends across 234 respondents from 47 countries. This survey sought to investigate preferred treatment types for unilateral vestibular dysfunction (UVD), bilateral vestibular dysfunction (BVD), superior canal dehiscence syndrome (SCDS), benign paroxysmal positional vertigo (BPPV), and Meniere’s disease (MD). Across respondents, UVD was most commonly treated pharmacologically with oral steroids, antiemetics, and Betahistine. The second most common treatment choice for UVD was vestibular rehabilitation therapy. BVD was most often treated with vestibular rehabilitation therapy. SCDS was most typically treated surgically thorough a variety of approaches. BPPV was most commonly treated with canalith repositioning, and treatment types were typically canal specific. Finally, MD was often treated with a variety of medications including Betahistine, diuretics, oral steroids, antiemetics, and gentamycin; the second most common treatment for MD was surgical.
These authors noted fairly heterogeneous treatment trends across respondents, regardless of practice location. However, the authors also noted a lack of empirical evidence supporting the efficacy of many of the drugs that were reportedly used for the various vestibular conditions.
Reference
Strupp M, Kern L, Laurell G, Lehner L, Grill E, Strobl R. (2025) World-wide survey on the treatment of peripheral vestibular disorders. Front Neurol 16.
Related Posts
Recent Posts
Where Y’at?
Where y’at? This common greeting in New Orleans isn’t asking for your location, it means how are you or what’s going on? As we look…
The Fabulous Audiology Chorus: You Know You Want To
The Fabulous Audiology Chorus is looking for voices to join in singing our national anthem at AAA 2025+HearTECH Expo. You’ve probably seen us at the…
AAA 2025 in New Orleans: GHOST TOUR
New Orleans is said to be one of the most haunted cities in the United States. According to Google, the city’s tumultuous history filled with…